SCIENTURE HOLDINGS, INC. Income (Loss) from Continuing Operations, Per Diluted Share
SCIENTURE HOLDINGS, INC. (SCNX) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$2.70 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was -$0.19.
- SCIENTURE HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$0.48.
- SCIENTURE HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was -$0.33.
- SCIENTURE HOLDINGS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2024-09-30 was -$1.34.
- SCIENTURE HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2025 was -$2.70.
- SCIENTURE HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2024 was -$5.41.
- SCIENTURE HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2023 was -$11.10.
- SCIENTURE HOLDINGS, INC. income (loss) from continuing operations, per diluted share for fiscal 2022 was -$3.47.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$2.70 10-K · filed 2026-03-30 | |||||||
| 2025-09-30 | -$0.19 10-Q · filed 2025-11-12 | -$0.94 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | -$0.48 10-Q · filed 2025-08-12 | -$0.83 10-Q · filed 2025-08-12 | ||||||
| 2025-03-31 | -$0.33 10-Q · filed 2025-05-12 | |||||||
| 2024-12-31 | -$5.41 10-K · filed 2026-03-30 | |||||||
| 2024-09-30 | -$1.34 10-Q · filed 2025-11-12 | -$7.10 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | -$1.16 10-Q · filed 2025-08-12 | -$6.75 10-Q · filed 2025-08-12 | ||||||
| 2024-03-31 | -$6.40 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | -$11.10 10-K · filed 2025-03-26 | -$5.76 10-K · filed 2024-04-22 | ||||||
| 2023-09-30 | -$0.11 10-Q · filed 2024-11-06 | -$0.07 10-Q · filed 2024-01-16 | -$4.84 10-Q · filed 2024-11-06 | -$0.87 10-Q · filed 2024-01-16 | ||||
| 2023-06-30 | -$3.27 10-Q · filed 2024-08-09 | -$2.90 10-Q · filed 2023-08-18 | -$4.95 10-Q · filed 2024-08-09 | -$3.41 10-Q · filed 2023-08-18 | ||||
| 2023-03-31 | -$1.69 10-Q · filed 2024-06-26 | |||||||
| 2022-12-31 | -$3.47 10-K · filed 2024-04-22 | |||||||
| 2022-09-30 | -$0.57 10-Q · filed 2024-01-16 | -$3.51 10-Q · filed 2024-01-16 | ||||||
| 2022-06-30 | -$2.04 10-Q · filed 2023-08-18 | -$3.81 10-Q · filed 2023-08-18 | ||||||
| 2017-12-31 | $0.01 10-K · filed 2018-03-02 | |||||||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | ||||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-04 | $0.00 10-Q · filed 2017-08-04 | ||||||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 | |||||||
| 2016-12-31 | -$0.04 10-K · filed 2018-03-02 | |||||||
| 2016-09-30 | -$0.01 10-Q · filed 2017-11-07 | -$0.03 10-Q · filed 2016-11-14 | -$0.03 10-Q · filed 2017-11-07 | -$0.07 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | -$0.02 10-Q · filed 2017-08-04 | -$0.03 10-Q · filed 2017-08-04 | ||||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | |||||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-02 | -$0.02 10-Q · filed 2015-11-02 | ||||||
| 2014-09-30 | -$0.01 10-Q · filed 2014-10-30 | -$0.05 10-Q · filed 2014-10-30 | ||||||
| 2014-06-30 | -$0.01 10-Q · filed 2014-08-21 | -$0.04 10-Q · filed 2014-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |